Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 20, 2026	FORM 4
4	Feb 17, 2026	FORM 4
144	Feb 17, 2026
4	Feb 13, 2026	FORM 4
SCHEDULE 13G/A	Feb 13, 2026
144	Feb 13, 2026
S-8	Feb 13, 2026	S-8
144	Feb 12, 2026
4	Feb 11, 2026	FORM 4
144	Feb 9, 2026
SCHEDULE 13G	Feb 5, 2026
SCHEDULE 13G	Jan 21, 2026
4	Jan 20, 2026	FORM 4
144	Jan 20, 2026
4	Jan 15, 2026	FORM 4
144	Jan 14, 2026
4	Jan 13, 2026	FORM 4
4	Jan 13, 2026	FORM 4
4	Jan 13, 2026	FORM 4
144	Jan 13, 2026
144	Jan 12, 2026
144	Jan 12, 2026
144	Jan 12, 2026

← Newer Page 5 of 17 · 406 filings Older →